Citation 66520

CUI,CB: TEZUKA,Y: KIKUCHI,T: NAKANO,H: TAMAOKI,T: PARK,JH:. (1990). CONSTITUENTS OF FERN, DAVALLIA MARIESII MOORE.I. ISOLATION AND STRUCTURES OF DAVALLIALACTONE AND A NEW FLAVANONE GLUCURONIDE.. 38(12)

Citation Details

Title	CONSTITUENTS OF FERN, DAVALLIA MARIESII MOORE.I. ISOLATION AND STRUCTURES OF DAVALLIALACTONE AND A NEW FLAVANONE GLUCURONIDE.
Authors	CUI,CB: TEZUKA,Y: KIKUCHI,T: NAKANO,H: TAMAOKI,T: PARK,JH:
Year	1990
Volume	38
Issue	12

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (2)

Davallia mariesii (DAVALLIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	COMMON COLD RELIEF	MEDICINAL FOLKLORE REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	None
2	ANALGESIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	ANTITUMOR ACTIVITY	MEDICINAL FOLKLORE REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	None
4	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CAFFEIC ACID	None
8	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CAFFEIC ACID 4-O-BETA-D-GLUCOSIDE	None
9	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID 4-O-BETA-D-GLUCOSIDE	WEAK ACTIVITY
10	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	COUMARIC ACID,PARA: 4-O-BETA-D-GLUCOSIDE	None
11	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,PARA: 4-O-BETA-D-GLUCOSIDE	WEAK ACTIVITY
12	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	DAVALLIALACTONE	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DAVALLIALACTONE	ACTIVE
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ERIODICTYOL-7-O-BETA-D-GLUCURONIDE,(DL):	None
15	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL-7-O-BETA-D-GLUCURONIDE,(DL):	WEAK ACTIVITY

Davallia mariesii (DAVALLIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIINFLAMMATORY ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
2	ANALGESIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	MISCELLANEOUS EFFECTS	MEDICINAL FOLKLORE REPORTED FOR	None	None
4	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	PROTEIN KINASE C AGONIZING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE

Show SPARQL Queries (1)